Helicobacter

Article	Citations
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high‐migrant Singaporean cohort	50
Proteomic Profiling of Extracellular Vesicles Reveals Potential Biomarkers for Helicobacter pylori Infection and Gastric Cancer	47
Investigation of endoscopic findings in nine cases of Helicobacter suis‐infected gastritis complicated by gastric mucosa‐associated lymphoid tissue lymphoma	44
Helicobacter pylori and the intestinal microbiome among healthy school‐age children	44
	35
Issue Information	33
Helicobacter macacaeMazF interplays with Escherichia coli homologs and enhances antibiotic tolerance	31
DNA starvation/stationary phase protection protein of Helicobacter pylori as a potential immunodominant antigen for infection detection	30
Constitutive programmed death ligand 1 expression protects gastric G‐cells from Helicobacter pylori–induced inflammation	30
Issue Information	28
Gastric Helicobacter pylori infection does not contribute to extraoral halitosis and its eradication cannot achieve substantial reduction of halitosis	27
New regimens as first‐line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial	27
Concentration‐dependent effect of amoxicillin against clinical strains of Helicobacter pylori	27
A case of neonatal thrombocytopenia due to maternal Helicobacter pylori‐associated immune thrombocytopenia	26
Helicobacter pylori, gastrointestinal microbiota, and immunotherapy	26
UreBimmunodominant epitope‐specificCD8+T‐cell responses were beneficial in reducing gastric symptoms inHelicobacter pylori‐infected individuals	25
Issue Information	23
Optimal Duration of Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis	22
Integrin‐Linked Kinase in the Development of Gastric Tumors Induced by Helicobacter pylori: Regulation and Prevention Potential	22
Characteristics of Helicobacter pylori Eradication Therapy in Patients 80 Years or Older Living in a Metropolitan Area: A Multicenter Retrospective Study	22
Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real‐World Evidence Study	22
Systematic Review and Meta‐Analysis: Bismuth Enhances the Efficacy for Eradication of Helicobacter pylori	21
Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection	21
After 28 Years, Professor David Y. Graham Says Goodbye and Helicobacter Welcomes a New Editor	21
Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review	20

Eradication rate and adherence with high‐dose amoxicillin and proton pump inhibitor as first‐line treatment for Helicobacter pylori infection: Experience from University Hospital in	20
Antimicrobial screening involving Helicobacter pylori of nano‐therapeutic compounds based on the amoxicillin antibiotic drug	20
Issue Information	20
Colloidal bismuth pectin‐containing quadruple therapy as the first‐line treatment of Helicobacter pylori infection: A multicenter, randomized, double‐blind, non‐inferiority clinical trial	20
Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children	20
Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes	20
Issue Information	19
REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020	19
Ethnic Inequity in the Current Approach to H. pylori Testing and Treatment: Linked Data Cohort Analysis	18
Probiotics mitigate Helicobacter pylori‐induced gastric inflammation and premalignant lesions in INS‐GAS mice with the modulation of gastrointestinal microbiota	17
A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy o	17
Evaluating the potency of zoliflodacin against Helicobacter pylori: In vitro activity and conserved GyrB target	17
The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults	17
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis	17
H. pylori predictors and outcomes among adults undergoing upper endoscopy at a Jamaican teaching hospital: A cross‐sectional study	17
Nationwide Trends in Helicobacter pylori Eradication Therapies in Korea: Impact of Guideline Updates on Treatment Practices	17
Low‐dose or high‐dose amoxicillin in vonoprazan‐based dual therapy for Helicobacter pylori eradication? A systematic review and meta‐analysis	16
Helicobacter pylori and cardiovascular risk: Only a dead Helicobacter is a good Helicobacter?	16
Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs	16
Urolithin B alleviates Helicobacter pylori‐induced inflammation and oxidative stress in mice	15
Transmission ofHelicobacter pyloribetween a human and two dogs: A case report	15
Meta‐analysis of Helicobacter pylori eradication therapy using vonoprazan as an acid suppressor compared with bismuth quadruple therapy	15
“True” Helicobacter pylori infection and non‐cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project	15
CRISPR‐based detection of Helicobacter pylori in stool samples	15
Persistent advanced periductal fibrosis is associated with cagA‐positive Helicobacter pylori infection in post‐praziquantel treatment of opisthorchiasis	15
	14
Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention	14
Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial	14
Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis	14
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)	14
Impact of body size on efficacy of high‐dose dual therapy for Helicobacter pylori eradication	13
A “new” option in Helicobacter pylori eradication: High‐dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting	13
Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China	12
	12
Effect ofHelicobacter pylorion immunotherapy is gaining more attention	12
Helicobacter pylori enhances HLA‐C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells	12
Exploring the capacities of ChatGPT: A comprehensive evaluation of its accuracy and repeatability in addressing helicobacter pylori‐related queries	12
The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response	12
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions	12
Assessing Accuracy of ChatGPT on Addressing Helicobacter pylori Infection‐Related Questions: A National Survey and Comparative Study	11
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First‐Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta‐Analysis	11
Eradication rates of Helicobacter pylori in treatment‐naive patients following 14‐day vonoprazan‐amoxicillin dual therapy: A multicenter randomized controlled trial in China	11
Eradication rate and safety of a “simplified rescue therapy”: 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in	11
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021	11
Correlation between the intensity of Helicobacter pylori colonization and severity of gastritis: Results of a prospective study	11
The Accuracy of Melting Curve–Based Multiplex Real‐Time PCR for Diagnosing Helicobacter pylori Resistance to Clarithromycin and Levofloxacin in Stool Specimens	10
	10
Letter to the Editor regarding the article: “Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy”	10
	10
Issue Information	10

Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship	10
Issue Information	10
Seroprevalence of Helicobacter pylori infection among schoolchildren in southern Taiwan—A 20‐year longitudinal follow‐up	10
The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection	10
	10
Innate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis	10
Effect of Helicobacter pylori eradication therapy on clinical and laboratory biomarkers associated with gastric damage in healthy school‐aged children: A randomized non‐blinded trial	10
Issue Information	10
Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential	9
	9
The association between Helicobacter pylori and gastrointestinal disorders during pregnancy: A Multicenter retrospective study	9
Combatting Helicobacter pylori: A Focus on Nanomaterials	9
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study	9
Helicobacter pylori regulated microRNA map of human gastric cells	9
The first 5 years of Helicobacter pylori research—With an emphasis on the United Kingdom	9
Corrigendum	9
Issue Information	9
	9
Forty years of Helicobacter pylori infection and changes in findings at esophagogastroduodenoscopy	9
Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article	8
Cover Image	8
Prophylactic immunization to Helicobacter pylori infection using spore vectored vaccines	8
	8
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans	8
	8
Long noncoding RNA NEAT1 promotes tumorigenesis in H. pylori gastric cancer by sponging miR‐30a to regulate COX‐2/BCL9 pathway	8
	8
Issue Information	8
Persistent advanced periductal fibrosis is and helicobacter pylori infection in post‐treatment of opisthorchiasis: Correspondence	8
Nationwide survey ofHelicobacter pyloriseropositivity and gastric atrophy in Zambia	8
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy	8
Gastric granulomas and Helicobacter pylori: An incidental relationship	8
Antagonizing roles of SHP1 in the pathogenesis of Helicobacter pylori infection	8
Efficacy and safety of vonoprazan‐based dual therapy and esomeprazole‐based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis	7
CCR6+ T helper cells and regulatory T cells in the blood and gastric mucosa during Helicobacter pylori infection	7
Application of WeChat platform in the management of patients infected with Helicobacter pylori	7
Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, Italy	7
Dynamic changes in antibiotic resistance genes and gut microbiota afterHelicobacter pylorieradication therapies	7
Real‐world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia	7
Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants—A review	7
Comparison of clinical outcomes and FOXP3, IL‐17A responses in Helicobacter pylori infection in children versus adults	6
Issue Information	6
Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study	6
Gastric Cancer Screening: Intention to Adhere and Patients' Perspective	6
Vonoprazan–Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial	6
Cost‐Effectiveness of Population‐Based Helicobacter pylori Screening With Eradication for Optimal Age of Implementation	6
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing	6
Efficacy of Tegoprazan‐Containing Sequential Eradication Treatment Compared to Esomeprazole‐Containing Sequential Eradication of Helicobacter pylori in South Korea, a Region With High Antimicro	6
Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development	6
Efficacy of Rifabutin‐Based Helicobacter pylori Eradication Regimen in Korea With High Prevalence of Tuberculosis Infection	6
Improved Patient Adherence to Family‐Based Helicobacter pylori Infection Control and Management Strategy in Central China and Its Influencing Factors	6
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial	6
Helicobacter pyloriresults in lysis and death after exposure to water	6
10‐Day and 14‐day high‐dose dual therapy for the treatment of Helicobacter pylori: A propensity score matching analysis	6
Evaluation of the effects of a proton pump inhibitor on Helicobacter pylori stool antigen testing	6
Rapid Antimicrobial Susceptibility Test of Helicobacter pylori to Metronidazole via Single‐Cell Raman Spectrometry	6
Helicobacter pylori induces gastric cancer via down‐regulating miR‐375 to inhibit dendritic cell maturation	6
Issue Information	6
States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis	5
	5
Time trend prevalence of helicobacter pylori infection and endoscopic findings in symptomatic children in Portugal: A retrospective study based on three time points in 2009, 2014, and 2019	5
Helicobacter pylori with trx1 high expression promotes gastric diseases via upregulating the IL23A/NF‐κB/IL8 pathway	5
Pepsinogen II in gastritis and Helicobacter pylori infection	5
Artificial Intelligence in Endoscopy for Predicting Helicobacter pylori Infection: A Systematic Review and Meta‐Analysis	5
Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes	5
Cover Image	5
Volatilomic signatures of different strains of Helicobacter pylori	5
Association between Helicobacter pylori infection and growth outcomes in children: A meta‐analysis	5
Association of Helicobacter pylori with migraine headaches and the effects of this infection and its eradication on the migraine characteristics in adults: A comprehensive systematic review and	5
Treatment failure is a key factor in the development of Helicobacter pylori resistance	5
Prevalence of Helicobacter pylori infection among Slovenian children and adolescents: A prospective cohort study	5
Helicobacter hepaticus promotes liver fibrosis through oxidative stress induced by hydrogenase in BALB/c mice	5
Comparison between the GastroPanel test and the serum pepsinogen assay interpreted with the ABC method—A prospective study	4
Perspectives from recent advances of Helicobacter pylori vaccines research	4
Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?	4
GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection	4
Two novel sequence types of Helicobacter pylori strains: The first report from Turkey	4
	4
Helicobacter pyloriCagA Promotes the Formation of Gallstones by Increasing the Permeability of Gallbladder Epithelial Cells	4
Discussion on the common controversies of Helicobacter pylori infection	4

Efficacy of genotypic susceptibility‐guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta‐analysis	4
Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases	4
Validation and improvement of a multiplex PCR method to detect murine Helicobacter species in feces samples of mice	4
Helicobacterspecies binding to the human gastric mucosa	4
Development of a modified ABC method among Helicobacter pylori infected but serum pepsinogen test‐negative individuals	4
Regulatory B cells (Bregs) in Helicobacter pylori chronic infection	4
Achieving Helicobacter pylori eradication in the primary treatment requires a deep integration of personalization and standardization	4
An increasing trend of gastric cancer deaths and inadequate preventive measures in elderly adults	4
Issue Information	4
	3
Issue Information	3
Helicobacter pylori‐Associated Extranodal Marginal Zone Lymphoma of Mucosa‐Associated Tissue in Children: A Multicenter Case Series	3
Correction to Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp‐EuReg)	3
Vonoprazan‐Amoxicillin Dual Therapy Versus Drug Sensitivity‐Based Individualized Therapy as a Rescue Regimen for Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial	3
Need for standardization and harmonization of Helicobacter pylori antimicrobial susceptibility testing	3
	3
Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost‐effectiveness analysis	3
Helicobacter pylori antigens as immunomodulators of immune system	3
Rebound of Reflux‐Related Symptoms After Helicobacter pylori Eradication in Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study	3
Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin	3
14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority contro	3
Doxycycline and minocycline inHelicobacter pyloritreatment: A systematic review and meta‐analysis	3
Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis	3
Helicobacter pylori Infection in Children: To Eradicate or Not to Eradicate?	3
Global Population Structure, Virulence Factors and Antibiotic Resistance of Helicobacter pylori: A Pooled Analysis of 4067 Isolates From 76 Countries	2
Diagnostic performance of linked color imaging for gastric cancer by Helicobacter pylori infection status: A subanalysis of the large‐scale, multicenter randomized controlled trial <	2
Comparative analysis of large language models in medical counseling: A focus on Helicobacter pylori infection	2
Genome‐wide association study of Helicobacter pylori serological status in Latin American children	2
YouTube as a source of information on Helicobacter pylori: Content and quality analysis	2
A comprehensive evaluation of an animal model for Helicobacter pylori‐associated stomach cancer: Fact and controversy	2
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review	2
Cardia and non‐cardia gastric cancer risk associated with Helicobacter pylori in East Asia and the West: A systematic review, meta‐analysis, and estimation of population attributable fraction	2
Research trends on vonoprazan‐based therapy for Helicobacter pylori eradication: A bibliometric analysis from 2015 to 2023	2
Helicobacter pylori infection and risk of cardiovascular disease	2
Transcriptomic remodeling of gastric cells by Helicobacter pylori outer membrane vesicles	2
Vonoprazan and amoxicillin dual therapy as the first‐line treatment of Helicobacter pylori infection: A systematic review and meta‐analysis	2
Issue Information	2
Impact of smoking on the eradication of Helicobacter pylori	2
Current role of tailored therapy in treating Helicobacter pylori infections. A systematic review, meta‐analysis and critical analysis	2
Helicobacter pylori‐positive chronic atrophic gastritis and cellular senescence	2
Interactions between Helicobacter pylori infection and host metabolic homeostasis: A comprehensive review	2
Helicobacter pylori infection and risk of multiple sclerosis: An updated meta‐analysis	2
Gastric mucosal swab as an alternative to biopsy for Helicobacter pylori detection	2
Vonoprazan and amoxicillin dual therapy for 14 days as the first‐line treatment of Helicobacter pylori infection: A non‐inferiority, randomized clinical trial	2
	2
Empirical Therapy Versus Tailored Therapy of Helicobacter pylori in Korea: Results of the K‐CREATE Study	2
Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis	2